RE Dickinson Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

RE Dickinson Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$3.6K	Hold	5	–	–	﹤0.01%	203
2024 Q3	$5.26K	Hold	5	–	–	﹤0.01%	184
2024 Q2	$5.26K	Hold	5	–	–	﹤0.01%	180
2024 Q1	$5K	Hold	5	–	–	﹤0.01%	182
2023 Q4	$4K	Hold	5	–	–	﹤0.01%	193
2023 Q3	$4K	Hold	5	–	–	﹤0.01%	211
2023 Q2	$4K	Hold	5	–	–	﹤0.01%	300
2023 Q1	$4K	Hold	5	–	–	﹤0.01%	322
2022 Q4	$4K	Hold	5	–	–	﹤0.01%	306
2022 Q3	$3K	Hold	5	–	–	﹤0.01%	206
2022 Q2	$3K	Hold	5	–	–	﹤0.01%	232
2022 Q1	$3K	Hold	5	–	–	﹤0.01%	250
2021 Q4	$3K	Buy	+5	New	+$3.07K	﹤0.01%	247

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RE Dickinson Investment Advisors's REGN Position: Q4 2024 in Review

RE Dickinson Investment Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q4 2024 at 5 shares worth $3.6K. The position accounts for ﹤0.01% of the portfolio, ranked #203.

RE Dickinson Investment Advisors first reported a position in REGN in Q4 2021 and has held it in 13 quarters since. The position peaked at $5.26K in Q3 2024. 1,321 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

RE Dickinson Investment Advisors held 5 shares of Regeneron Pharmaceuticals worth $3.6K as of Q4 2024.
RE Dickinson Investment Advisors left its Regeneron Pharmaceuticals share count unchanged in Q4 2024.
Regeneron Pharmaceuticals made up ﹤0.01% of RE Dickinson Investment Advisors's portfolio in Q4 2024, its #203 holding.
RE Dickinson Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 13 quarters since.
RE Dickinson Investment Advisors's Regeneron Pharmaceuticals position peaked at $5.26K in Q3 2024.
1,321 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on RE Dickinson Investment Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.